Literature DB >> 6743827

Filterability of subpopulations of leukocytes: effect of pentoxifylline.

E A Schmalzer, S Chien.   

Abstract

Human leukocytes were separated by density into two fractions, one containing predominantly granulocytes (FI) and the other, lymphocytes and monocytes (FII). The filterability of these fractions and their mixture was determined from the pressure measured during constant flow through 5-microns Nuclepore filters. The pressure-time curve of FI indicates the behavior of a relatively homogeneous cell population. The FII pressure-time curve can be analyzed to distinguish the effect of the more numerous and more filterable lymphocytes from that of the sparser but less filterable monocytes. Pressure generated by mixed leukocytes, which had been treated with 1 and 10 mmol/L of pentoxifylline (PTX) or its metabolite I, was substantially less than untreated control; at 10 mmol/L, the pressure was reduced to about 50% of control. PTX appears to affect the filterability of monocytes and polymorphonuclear leukocytes but not lymphocytes. Scanning electron microscopy showed an inhibition of protopod formation in the treated granulocytes. The degree of cell adhesion to the filter, as measured by the number of cells remaining on the outflow side of the filter, was similar in all groups (FI and FII, treated and untreated). The results indicate that the variations in filterability between the leukocyte subpopulations and the improvement by PTX treatment reflect differences in the cells' ability to deform under the test conditions.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6743827

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  18 in total

1.  Cellular mechanisms of acute lung injury: implications for future treatment in the adult respiratory distress syndrome.

Authors:  S C Donnelly; C Haslett
Journal:  Thorax       Date:  1992-04       Impact factor: 9.139

2.  Pentoxifylline in arterial disease of the legs.

Authors:  R Verhaeghe; M Verstraete
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  Attenuation of spontaneous pseudopod formation in human neutrophils by pentoxifylline.

Authors:  P M Wong; G W Schmid-Schönbein
Journal:  Cell Biophys       Date:  1991-06

4.  Efficacy, toxicity, and pharmacokinetics of pentoxifylline and its analogs in experimental Staphylococcus aureus infections.

Authors:  E G Maderazo; S Breaux; C L Woronick; P J Krause
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

5.  The effect of pentoxifylline on spontaneous and experimental metastasis of the mouse Neuro2a neuroblastoma.

Authors:  A Amirkhosravi; G Warnes; J Biggerstaff; Z Malik; K May; J L Francis
Journal:  Clin Exp Metastasis       Date:  1997-07       Impact factor: 5.150

6.  Pentoxifylline modulation of plasma membrane functions in human polymorphonuclear leukocytes.

Authors:  W L Hand; M L Butera; N L King-Thompson; D L Hand
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

7.  Effect of ingested pentoxifylline on neutrophil superoxide anion production.

Authors:  S P Crouch; J Fletcher
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

8.  Effect of pentoxifylline on decreased in vitro mononuclear leucocyte chemotaxis in vascular and polysystemic autoimmune diseases.

Authors:  Z Szekanecz; G Szabó; I Sonkoly; Z Bedö; G Szegedi
Journal:  Agents Actions       Date:  1991-07

9.  Pentoxifylline inhibits actin polymerization in human neutrophils after stimulation by chemoattractant factor.

Authors:  G Freyburger; F Belloc; M R Boisseau
Journal:  Agents Actions       Date:  1990-08

Review 10.  Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy.

Authors:  A Ward; S P Clissold
Journal:  Drugs       Date:  1987-07       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.